Phase II trial of carbon-ion radiotherapy for head and neck cancer(HIMAT1301)

Phase II trial of carbon-ion radiotherapy for head and neck cancer(HIMAT1301) - Phase II trial of carbon-ion radiotherapy for head and neck cancer(HIMAT1301)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012414

Enrollment

Registered

2013-12-01

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-squamous cell carcinoma at head and neck region

Interventions

64GyE/16Fr/4weeks or 57.6GyE/16Fr/4weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Non-squamous cell carcinoma with pathological diagnosis. 2)N0M0 or N1M0 3)Performance status:0-2 4)the patient with over 6months prognosis 5)other

Exclusion criteria

Exclusion criteria: 1)with history of radiotherapy 2)under 2weeks after last chemotherapy 3)with another active cancer 4)with active infection 5)with metal material could not removed 6)other

Design outcomes

Primary

Measure	Time frame
3year local control rate	—

Secondary

Measure	Time frame
overall survival rate cause specific survival rate normal tissue reaction	—

Countries

Japan

Contacts

Public ContactHiroaki Suefuji

Ion Beam Therapy Center,SAGA HIMAT Foundation radiology

sufg@saga-himat.jp0942-81-1897

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026